Advertisement
The new report entitled Mild Cognitive Impairment: An Off-Label Marketwith Significant Unmet Need and High Prevalence Carries SubstantialOpportunity finds that, following its launch in 2010, Flurizan will replaceAricept as the gold standard for mild cognitive impairment. Surveyed U.S.neurologists indicate that they would prescribe Flurizan to 20% of theirpatients with mild cognitive impairment and the report forecasts that Flurizanwill earn a 23% patient share in the U.S. market in 2016.
Advertisement
"Clinical trial data suggests that Flurizan has disease-modifyingproperties, an asset that interviewed experts expect will make the drug moreeffective at delaying the onset of Alzheimer's disease than currentlyavailable drugs," said Bethany Kiernan, Ph.D., analyst at Decision Resources."Flurizan's safety and tolerability profile is also better than other emergingcompetitors, and this, along with its efficacy, will make it the gold standardin the treatment of mild cognitive impairment in 2016."
About the Report
Mild Cognitive Impairment: An Off-Label Market with Significant Unmet Needand High Prevalence Carries Substantial Opportunity is a DecisionBase 2008report from Decision Resources. DecisionBase 2008 combines market forecastswith clinical and commercial end points to assess market share projections in35 indications. These outputs are driven by quantitative and qualitativeprimary research. DecisionBase 2008 provides detailed market share, patientshare, and price-per-day projections for emerging drugs in development. Themarket share projections are based on prescriber surveys that comparephysicians' expectations of a potential target product profile with anemerging product profile of the leading drugs in development.
The report can be purchased by contacting Decision Resources. Members ofthe media may request an interview with an analyst.
About Decision Resources
Decision Resources, Inc. (www.decisionresources.com) is a world leader inmarket research publications, advisory services, and consulting designed tohelp clients shape strategy, allocate resources, and master their chosenmarkets. Decision Resources is a Decision Resources, Inc. company.All company, brand, or product names contained in this document may be trademarks or registered trademarks of their respective holders. For more information, contact: Elizabeth Marshall Decision Resources, Inc. 781-296-2563 [email protected]
SOURCE Decision Resources